Researchers are still elucidating how weight loss after bariatric surgery affects the gut microbiome and overall health.
The impact of eradicated Helicobacter pylori on the pediatric gastric microbial community structure shows restoration of bacterial diversity consistent with noninfected children in the same endemic region.
Measuring succinate levels before bariatric surgery may serve as a predictive marker for remission of type 2 diabetes.
Patients receiving gastric acid inhibitors have an increase in prescriptions of anti-allergic drugs.
Researchers assessed the effects of exercise training on bone structure and metabolism after Roux-en-Y gastric bypass surgery.
Bariatric surgery can impact rheumatic diseases, apart from it being an effective weight loss option for people with obesity and severe associated comorbidities.
Type 2 diabetes was linked to an increased risk for gastric cancer (adjusted hazard ratio, 1.73). Stratified statistical analysis demonstrated a significantly higher risk for gastric cardia cancer (adjusted hazard ratio, 3.40) and a significantly increased risk in those with suboptimal glycemic control (adjusted hazard ratio, 1.68).
The FDA has granted Breakthrough Therapy designation to teplizumab (PRV-031; Provention Bio), for the prevention or delay of clinical T1D in those at risk of developing the disease.
Complication rates similar for patients with, without ESKD undergoing laparoscopic sleeve gastrectomy.
Prucalopride 2 mg daily was superior to placebo in improving symptoms in patients with predominantly idiopathic gastroparesis.
The FDA has approved updates to the Orbera Intragastric Balloon System labeling to improve patient safety.
A case report suggests that endoscopic techniques may have utility in the diagnosis of the gastric involvement that can occur in follicular lymphoma.
Among children under age 5 years with acute gastroenteritis, Lactobacillus reuteri DSM 17938 as an adjunct to rehydration therapy did not reduce the duration of diarrhea compared with placebo.